Yim Ping Mo, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Yim Ping Mo’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Medicaid work
$24,620 in 2023
Medicaid paid $24,620 for 523 billed services this clinician did in 2023, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 277 | $16,604 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 56 | $5,349 |
| PHYSICAL PERFORMANCE TEST | 40 | $1,464 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 29 | $468 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 12 | $450 |
| Return visit (30+ min) | 13 | $284 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 27 | $0 |
| Advance care plan or similar legal document present in the medical record (COA) | 27 | $0 |
| BODY MASS INDEX DOCD | 27 | $0 |
| Screening for depression performed (DEM) | 15 | $0 |
| 2023 | 523 | 10 | 46 | $24,620 |
| 2022 | 938 | 12 | 46 | $23,135 |
| 2021 | 1,433 | 13 | 61 | $31,863 |
| 2020 | 728 | 12 | 37 | $19,195 |
| 2019 | 376 | 6 | 27 | $1,439 |
| 2018 | 281 | 1 | 38 | $0 |
See the largest Medicaid services in earlier years
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 96 | $12,701 |
| Short return visit (20+ min) | 271 | $9,819 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 57 | $353 |
| PHYSICAL PERFORMANCE TEST | 32 | $263 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 85 | $0 |
| Advance care plan or similar legal document present in the medical record (COA) | 86 | $0 |
| Medication list documented in medical record (COA) | 87 | $0 |
| BODY MASS INDEX DOCD | 90 | $0 |
| Screening mammography results documented and reviewed (PV) | 12 | $0 |
| Cervical cancer screening results documented and reviewed (PV) | 12 | $0 |
| COLORECTAL CANCER SCREENING RESULTS DOC&REV | 27 | $0 |
| Screening for depression performed (DEM) | 83 | $0 |
2021
| Short return visit (20+ min) | 542 | $19,200 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 110 | $11,045 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 122 | $1,020 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 41 | $338 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $260 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 110 | $0 |
| Advance care plan or similar legal document present in the medical record (COA) | 111 | $0 |
| Medication list documented in medical record (COA) | 92 | $0 |
| BODY MASS INDEX DOCD | 120 | $0 |
| Screening mammography results documented and reviewed (PV) | 12 | $0 |
| Cervical cancer screening results documented and reviewed (PV) | 26 | $0 |
| COLORECTAL CANCER SCREENING RESULTS DOC&REV | 25 | $0 |
2020
| Short return visit (20+ min) | 389 | $11,914 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 60 | $5,790 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 58 | $1,301 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 21 | $189 |
| Patient screened for future fall risk; documentation of no falls in the past year or only 1 fall without injury in the past year (GER) | 26 | $0 |
| Advance care plan or similar legal document present in the medical record (COA) | 26 | $0 |
| Medication list documented in medical record (COA) | 28 | $0 |
| BODY MASS INDEX DOCD | 28 | $0 |
| Screening mammography results documented and reviewed (PV) | 27 | $0 |
| Cervical cancer screening results documented and reviewed (PV) | 27 | $0 |
| COLORECTAL CANCER SCREENING RESULTS DOC&REV | 12 | $0 |
| Screening for depression performed (DEM) | 26 | $0 |
2019
| Short return visit (20+ min) | 285 | $1,439 |
| Screening mammography results documented and reviewed (PV) | 15 | $0 |
| Cervical cancer screening results documented and reviewed (PV) | 17 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 22 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 20 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 17 | $0 |
2018
| Short return visit (20+ min) | 281 | $0 |
Drugs they prescribed that Part D paid
$135,109
Pharmacies billed $135,109 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
541 generic and fewer than 11 brand-name prescriptions · $135,109 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 17 | $20,575 | $1,210 |
| Atorvastatin | 85 | $1,086 | $13 |
| Losartan | 69 | $607 | $9 |
| Rosuvastatin | 12 | $446 | $37 |
| Metoprolol | 31 | $433 | $14 |
See all 12 drugs
| Eliquis | 17 | $20,575 | $1,210 |
| Atorvastatin | 85 | $1,086 | $13 |
| Losartan | 69 | $607 | $9 |
| Rosuvastatin | 12 | $446 | $37 |
| Metoprolol | 31 | $433 | $14 |
| Diclofenac | 15 | $415 | $28 |
| Pravastatin | 13 | $243 | $19 |
| Levothyroxine | 18 | $224 | $12 |
| Amlodipine Besylate | 27 | $198 | $7 |
| Tamsulosin | 13 | $148 | $11 |
| Simvastatin | 25 | $119 | $5 |
| Metformin Hcl Er | 17 | $99 | $6 |
Year by year
| 2024 | 661 | 240 | None | None | $135,109 |
| 2023 | 4,961 | 555 | None | 13% | $760,537 |
| 2022 | 6,011 | 526 | 0% (14) | 16% | $839,869 |
| 2021 | 4,735 | 463 | None | 15% | $573,933 |
| 2020 | 3,297 | 327 | None | None | $356,123 |
| 2019 | 2,537 | 255 | None | None | $267,118 |
| 2018 | 2,215 | 259 | None | None | $192,010 |
| 2017 | 1,079 | 198 | None | 18% | $86,567 |
| 2016 | 285 | 83 | 0% (0) | None | $10,791 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 74 drugs
| Jardiance | 51 | $90,020 | $1,765 |
| Rybelsus | 36 | $73,813 | $2,050 |
| Vemlidy | 51 | $67,860 | $1,331 |
| Xigduo Xr | 46 | $67,659 | $1,471 |
| Farxiga | 39 | $64,063 | $1,643 |
| Eliquis | 43 | $50,736 | $1,180 |
| Synjardy Xr | 30 | $50,535 | $1,684 |
| Prolia | 23 | $35,497 | $1,543 |
| Tradjenta | 23 | $31,212 | $1,357 |
| Stiolto Respimat | 21 | $25,009 | $1,191 |
| Anoro Ellipta | 12 | $17,534 | $1,461 |
| Atorvastatin | 641 | $10,030 | $16 |
| Losartan | 555 | $8,336 | $15 |
| Toujeo Solostar | 12 | $7,595 | $633 |
| Albuterol Sulfate | 17 | $5,180 | $305 |
| Diclofenac | 237 | $4,177 | $18 |
| Febuxostat | 36 | $3,586 | $100 |
| Amlodipine Besylate | 242 | $2,931 | $12 |
| Pravastatin | 145 | $2,817 | $19 |
| Metoprolol | 164 | $2,482 | $15 |
| Fluocinonide | 38 | $2,402 | $63 |
| Losartan-Hydrochlorothiazide | 89 | $2,330 | $26 |
| Albuterol Sulfate Hfa | 54 | $2,328 | $43 |
| Tamsulosin | 131 | $2,283 | $17 |
| Shingrix | 11 | $2,171 | $197 |
| Metformin Hcl Er | 161 | $1,681 | $10 |
| Glipizide Er | 40 | $1,583 | $40 |
| Alendronate | 115 | $1,395 | $12 |
| Triamcinolone Acetonide | 135 | $1,374 | $10 |
| Tenofovir Disoproxil | 16 | $1,359 | $85 |
| Omega-3 Acid Ethyl Esters | 25 | $1,307 | $52 |
| Pioglitazone | 30 | $1,197 | $40 |
| Finasteride | 56 | $1,128 | $20 |
| Simvastatin | 102 | $1,049 | $10 |
| Mirtazapine | 41 | $997 | $24 |
| Rosuvastatin | 46 | $958 | $21 |
| Montelukast | 45 | $940 | $21 |
| Levothyroxine | 48 | $858 | $18 |
| Isosorbide Mononitrate Er | 19 | $852 | $45 |
| Lisinopril | 77 | $749 | $10 |
| Levetiracetam | 13 | $733 | $56 |
| Metformin | 74 | $724 | $10 |
| Hydroxyzine | 21 | $635 | $30 |
| Famotidine | 63 | $596 | $9 |
| Benazepril | 32 | $591 | $18 |
| Valsartan | 13 | $570 | $44 |
| Fluticasone Propionate | 58 | $558 | $10 |
| Allopurinol | 49 | $557 | $11 |
| Olmesartan Medoxomil | 21 | $517 | $25 |
| Memantine | 14 | $490 | $35 |
| Naproxen | 13 | $466 | $36 |
| Carvedilol | 33 | $465 | $14 |
| Clotrimazole-Betamethasone | 24 | $419 | $17 |
| Atenolol | 31 | $388 | $13 |
| Clopidogrel | 26 | $322 | $12 |
| Irbesartan | 13 | $319 | $25 |
| Spironolactone | 24 | $307 | $13 |
| Hydrocortisone | 17 | $302 | $18 |
| Donepezil | 17 | $291 | $17 |
| Gabapentin | 20 | $255 | $13 |
| Meclizine | 21 | $254 | $12 |
| Ciclopirox | 12 | $245 | $20 |
| Terazosin | 17 | $244 | $14 |
| Lisinopril-Hydrochlorothiazide | 20 | $224 | $11 |
| Pantoprazole | 16 | $188 | $12 |
| Hydrochlorothiazide | 21 | $186 | $9 |
| Sertraline | 12 | $174 | $14 |
| Furosemide | 30 | $173 | $6 |
| Omeprazole | 24 | $172 | $7 |
| Chlorthalidone | 11 | $150 | $14 |
| Meloxicam | 21 | $136 | $6 |
| Glipizide | 12 | $118 | $10 |
| Lovastatin | 14 | $117 | $8 |
| Zolpidem | 13 | $117 | $9 |
2022: 84 drugs
| Jardiance | 112 | $178,431 | $1,593 |
| Tradjenta | 41 | $58,986 | $1,439 |
| Eliquis | 47 | $58,525 | $1,245 |
| Farxiga | 38 | $57,941 | $1,525 |
| Rybelsus | 26 | $51,229 | $1,970 |
| Vemlidy | 34 | $42,854 | $1,260 |
| Stiolto Respimat | 35 | $42,512 | $1,215 |
| Prolia | 27 | $38,370 | $1,421 |
| Januvia | 15 | $21,689 | $1,446 |
| Xigduo Xr | 14 | $19,334 | $1,381 |
| Synjardy Xr | 13 | $19,096 | $1,469 |
| Trulicity | 14 | $17,763 | $1,269 |
| Anoro Ellipta | 12 | $16,351 | $1,363 |
| Lantus Solostar | 28 | $12,400 | $443 |
| Symbicort | 20 | $9,680 | $484 |
| Atorvastatin | 703 | $8,831 | $13 |
| Losartan | 635 | $7,031 | $11 |
| Albuterol Sulfate | 22 | $6,055 | $275 |
| Febuxostat | 40 | $4,662 | $117 |
| Diclofenac | 296 | $4,429 | $15 |
| Losartan-Hydrochlorothiazide | 110 | $3,473 | $32 |
| Albuterol Sulfate Hfa | 75 | $3,205 | $43 |
| Metoprolol | 202 | $2,934 | $15 |
| Fluocinonide | 40 | $2,771 | $69 |
| Tamsulosin | 162 | $2,408 | $15 |
| Mitigare | 12 | $2,288 | $191 |
| Amlodipine Besylate | 284 | $2,135 | $8 |
| Triamcinolone Acetonide | 165 | $2,077 | $13 |
| Omega-3 Acid Ethyl Esters | 40 | $2,017 | $50 |
| Metformin Hcl Er | 219 | $1,999 | $9 |
| Alendronate | 197 | $1,934 | $10 |
| Pravastatin | 100 | $1,735 | $17 |
| Glipizide Er | 54 | $1,512 | $28 |
| Finasteride | 82 | $1,455 | $18 |
| Raloxifene | 16 | $1,414 | $88 |
| Mirtazapine | 38 | $1,346 | $35 |
| Simvastatin | 157 | $1,281 | $8 |
| Metformin | 123 | $1,209 | $10 |
| Levothyroxine | 48 | $1,102 | $23 |
| Pioglitazone | 30 | $1,078 | $36 |
| Tenofovir Disoproxil | 13 | $1,038 | $80 |
| Montelukast | 47 | $1,025 | $22 |
| Rosuvastatin | 52 | $968 | $19 |
| Valsartan-Hydrochlorothiazide | 12 | $806 | $67 |
| Memantine | 15 | $801 | $53 |
| Famotidine | 81 | $772 | $10 |
| Proctozone-Hc | 29 | $672 | $23 |
| Olmesartan Medoxomil | 23 | $658 | $29 |
| Hydrocortisone | 26 | $654 | $25 |
| Pantoprazole | 62 | $647 | $10 |
| Lisinopril | 88 | $625 | $7 |
| Clotrimazole-Betamethasone | 24 | $598 | $25 |
| Lorazepam | 19 | $555 | $29 |
| Allopurinol | 49 | $554 | $11 |
| Gabapentin | 23 | $475 | $21 |
| Benazepril | 44 | $451 | $10 |
| Hydroxyzine | 16 | $447 | $28 |
| Fluticasone Propionate | 56 | $445 | $8 |
| Irbesartan-Hydrochlorothiazide | 12 | $418 | $35 |
| Meclizine | 37 | $417 | $11 |
| Ciclopirox | 13 | $399 | $31 |
| Irbesartan | 18 | $383 | $21 |
| Carvedilol | 29 | $377 | $13 |
| Naproxen | 25 | $376 | $15 |
| Felodipine Er | 13 | $353 | $27 |
| Terazosin | 24 | $346 | $14 |
| Clopidogrel | 31 | $332 | $11 |
| Omeprazole | 35 | $292 | $8 |
| Hydrochlorothiazide | 26 | $263 | $10 |
| Atenolol | 35 | $263 | $8 |
| Donepezil | 20 | $243 | $12 |
| Levetiracetam | 11 | $228 | $21 |
| Chlorthalidone | 13 | $216 | $17 |
| Isosorbide Mononitrate Er | 15 | $210 | $14 |
| Glipizide | 21 | $199 | $9 |
| Furosemide | 37 | $175 | $5 |
| Meloxicam | 24 | $167 | $7 |
| Spironolactone | 16 | $155 | $10 |
| Metoprolol | 15 | $146 | $10 |
| Escitalopram | 12 | $136 | $11 |
| Lisinopril-Hydrochlorothiazide | 17 | $113 | $7 |
| Lovastatin | 13 | $92 | $7 |
| Chlorhexidine Gluconate | 14 | $86 | $6 |
| Ibuprofen | 14 | $77 | $5 |
2021: 78 drugs
| Jardiance | 84 | $131,929 | $1,571 |
| Eliquis | 32 | $41,615 | $1,300 |
| Januvia | 26 | $35,327 | $1,359 |
| Trulicity | 15 | $33,735 | $2,249 |
| Vemlidy | 19 | $30,164 | $1,588 |
| Stiolto Respimat | 24 | $27,938 | $1,164 |
| Farxiga | 13 | $20,047 | $1,542 |
| Anoro Ellipta | 16 | $19,996 | $1,250 |
| Breo Ellipta | 13 | $14,264 | $1,097 |
| Advair Diskus | 14 | $13,343 | $953 |
| Janumet Xr | 11 | $10,209 | $928 |
| Lantus Solostar | 21 | $8,596 | $409 |
| Febuxostat | 38 | $8,052 | $212 |
| Atorvastatin | 531 | $6,820 | $13 |
| Losartan | 422 | $4,930 | $12 |
| Diclofenac | 203 | $3,737 | $18 |
| Albuterol Sulfate Hfa | 61 | $2,894 | $47 |
| Fluocinonide | 37 | $2,830 | $76 |
| Losartan-Hydrochlorothiazide | 101 | $2,660 | $26 |
| Metoprolol | 154 | $2,536 | $16 |
| Tamsulosin | 142 | $2,193 | $15 |
| Omega-3 Acid Ethyl Esters | 41 | $2,151 | $52 |
| Triamcinolone Acetonide | 128 | $2,062 | $16 |
| Amlodipine Besylate | 223 | $1,627 | $7 |
| Metformin Hcl Er | 183 | $1,565 | $9 |
| Alendronate | 170 | $1,502 | $9 |
| Ventolin Hfa | 15 | $1,285 | $86 |
| Rosuvastatin | 34 | $1,257 | $37 |
| Simvastatin | 139 | $1,054 | $8 |
| Hydrocortisone | 28 | $1,034 | $37 |
| Levothyroxine | 43 | $992 | $23 |
| Glipizide Er | 36 | $909 | $25 |
| Lidocaine | 33 | $905 | $27 |
| Memantine | 16 | $863 | $54 |
| Finasteride | 62 | $835 | $13 |
| Raloxifene | 17 | $820 | $48 |
| Pravastatin | 53 | $815 | $15 |
| Famotidine | 68 | $760 | $11 |
| Montelukast | 50 | $713 | $14 |
| Metformin | 81 | $703 | $9 |
| Allopurinol | 56 | $702 | $13 |
| Ulticare Pen Needle | 11 | $668 | $61 |
| Felodipine Er | 16 | $601 | $38 |
| Lisinopril | 61 | $594 | $10 |
| Irbesartan-Hydrochlorothiazide | 14 | $569 | $41 |
| Oxybutynin Chloride Er | 11 | $549 | $50 |
| Nifedipine Er | 11 | $518 | $47 |
| Fluticasone Propionate | 55 | $492 | $9 |
| Irbesartan | 16 | $490 | $31 |
| Meclizine | 27 | $413 | $15 |
| Hydrochlorothiazide | 44 | $410 | $9 |
| Proctozone-Hc | 14 | $397 | $28 |
| Clotrimazole-Betamethasone | 16 | $396 | $25 |
| Omeprazole | 47 | $352 | $7 |
| Mirtazapine | 21 | $350 | $17 |
| Metoprolol | 24 | $342 | $14 |
| Terazosin | 24 | $327 | $14 |
| Naproxen | 39 | $327 | $8 |
| Pantoprazole | 40 | $325 | $8 |
| Benazepril | 36 | $289 | $8 |
| Gabapentin | 21 | $267 | $13 |
| Hydroxyzine | 22 | $255 | $12 |
| Atenolol | 32 | $255 | $8 |
| Carvedilol | 17 | $245 | $14 |
| Glipizide | 24 | $243 | $10 |
| Ciclopirox | 11 | $238 | $22 |
| Clopidogrel | 22 | $234 | $11 |
| Lisinopril-Hydrochlorothiazide | 23 | $226 | $10 |
| Lorazepam | 18 | $200 | $11 |
| Furosemide | 17 | $149 | $9 |
| Spironolactone | 14 | $148 | $11 |
| Lovastatin | 18 | $138 | $8 |
| Donepezil | 11 | $73 | $7 |
| Chlorhexidine Gluconate | 11 | $62 | $6 |
| Prednisone | 16 | $60 | $4 |
| Meloxicam | 11 | $58 | $5 |
| Ciprofloxacin | 13 | $57 | $4 |
| Alprazolam | 12 | $34 | $3 |
2020: 66 drugs
| Jardiance | 25 | $33,326 | $1,333 |
| Vemlidy | 24 | $28,202 | $1,175 |
| Eliquis | 27 | $26,688 | $988 |
| Januvia | 19 | $25,079 | $1,320 |
| Anoro Ellipta | 16 | $18,097 | $1,131 |
| Stiolto Respimat | 21 | $16,329 | $778 |
| Febuxostat | 31 | $13,318 | $430 |
| Advair Diskus | 13 | $12,634 | $972 |
| Spiriva | 12 | $7,441 | $620 |
| Losartan-Hydrochlorothiazide | 73 | $4,212 | $58 |
| Albuterol Sulfate | 11 | $3,948 | $359 |
| Diclofenac | 156 | $3,934 | $25 |
| Losartan | 268 | $3,844 | $14 |
| Atorvastatin | 272 | $3,266 | $12 |
| Proair Hfa | 25 | $2,729 | $109 |
| Fluocinonide | 29 | $2,567 | $89 |
| Metoprolol | 81 | $1,853 | $23 |
| Colchicine | 11 | $1,763 | $160 |
| Tamsulosin | 83 | $1,409 | $17 |
| Albuterol Sulfate Hfa | 22 | $1,174 | $53 |
| Triamcinolone Acetonide | 82 | $1,112 | $14 |
| Raloxifene | 24 | $1,109 | $46 |
| Metformin Hcl Er | 111 | $1,079 | $10 |
| Amlodipine Besylate | 146 | $1,035 | $7 |
| Omega-3 Acid Ethyl Esters | 19 | $965 | $51 |
| Alendronate | 118 | $938 | $8 |
| Simvastatin | 119 | $918 | $8 |
| Ventolin Hfa | 15 | $842 | $56 |
| Finasteride | 43 | $809 | $19 |
| Montelukast | 52 | $786 | $15 |
| Allopurinol | 56 | $778 | $14 |
| Metformin | 70 | $693 | $10 |
| Lidocaine | 27 | $679 | $25 |
| Levothyroxine | 24 | $676 | $28 |
| Hydrocortisone | 24 | $633 | $26 |
| Famotidine | 56 | $598 | $11 |
| Hydrochlorothiazide | 48 | $495 | $10 |
| Triazolam | 11 | $492 | $45 |
| Irbesartan-Hydrochlorothiazide | 13 | $436 | $34 |
| Pravastatin | 21 | $436 | $21 |
| Glipizide Er | 19 | $402 | $21 |
| Fluticasone Propionate | 36 | $341 | $9 |
| Terazosin | 20 | $291 | $15 |
| Benazepril | 37 | $283 | $8 |
| Lisinopril | 40 | $275 | $7 |
| Pantoprazole | 28 | $273 | $10 |
| Rosuvastatin | 26 | $266 | $10 |
| Proctozone-Hc | 11 | $262 | $24 |
| Naproxen | 32 | $254 | $8 |
| Hydroxyzine | 17 | $241 | $14 |
| Clopidogrel | 21 | $241 | $11 |
| Meclizine | 20 | $240 | $12 |
| Omeprazole | 46 | $229 | $5 |
| Ciclopirox | 11 | $204 | $19 |
| Metoprolol | 22 | $197 | $9 |
| Gabapentin | 24 | $194 | $8 |
| Spironolactone | 14 | $181 | $13 |
| Hydralazine | 11 | $171 | $16 |
| Lisinopril-Hydrochlorothiazide | 20 | $167 | $8 |
| Atenolol | 18 | $162 | $9 |
| Glipizide | 16 | $131 | $8 |
| Glimepiride | 12 | $129 | $11 |
| Lorazepam | 15 | $90 | $6 |
| Ibuprofen | 15 | $79 | $5 |
| Prednisone | 22 | $78 | $4 |
| Furosemide | 12 | $63 | $5 |
2019: 53 drugs
| Jardiance | 20 | $27,810 | $1,390 |
| Trulicity | 14 | $24,007 | $1,715 |
| Eliquis | 18 | $18,076 | $1,004 |
| Januvia | 13 | $16,900 | $1,300 |
| Stiolto Respimat | 28 | $16,533 | $590 |
| Vemlidy | 14 | $15,461 | $1,104 |
| Spiriva | 13 | $5,838 | $449 |
| Fluocinonide | 37 | $3,358 | $91 |
| Diclofenac | 102 | $2,733 | $27 |
| Proair Hfa | 35 | $2,535 | $72 |
| Atorvastatin | 145 | $1,958 | $14 |
| Metoprolol | 65 | $1,874 | $29 |
| Raloxifene | 16 | $1,841 | $115 |
| Losartan | 205 | $1,825 | $9 |
| Ventolin Hfa | 29 | $1,618 | $56 |
| Duloxetine | 14 | $1,172 | $84 |
| Tamsulosin | 61 | $1,020 | $17 |
| Losartan-Hydrochlorothiazide | 66 | $950 | $14 |
| Alendronate | 103 | $875 | $8 |
| Triamcinolone Acetonide | 62 | $808 | $13 |
| Triazolam | 16 | $787 | $49 |
| Amlodipine Besylate | 90 | $729 | $8 |
| Simvastatin | 110 | $702 | $6 |
| Levothyroxine | 27 | $673 | $25 |
| Allopurinol | 34 | $653 | $19 |
| Warfarin | 27 | $653 | $24 |
| Famotidine | 46 | $619 | $13 |
| Metformin | 63 | $557 | $9 |
| Nifedipine Er | 22 | $554 | $25 |
| Metformin Hcl Er | 62 | $522 | $8 |
| Lidocaine | 21 | $486 | $23 |
| Glipizide Er | 18 | $404 | $22 |
| Fluticasone Propionate | 44 | $381 | $9 |
| Finasteride | 18 | $359 | $20 |
| Benazepril | 37 | $323 | $9 |
| Montelukast | 27 | $309 | $11 |
| Naproxen | 33 | $282 | $9 |
| Rosuvastatin | 15 | $275 | $18 |
| Pravastatin | 13 | $263 | $20 |
| Lisinopril | 34 | $259 | $8 |
| Hydrochlorothiazide | 32 | $216 | $7 |
| Meclizine | 16 | $201 | $13 |
| Atenolol | 13 | $196 | $15 |
| Gabapentin | 21 | $192 | $9 |
| Terazosin | 13 | $191 | $15 |
| Glipizide | 13 | $183 | $14 |
| Omeprazole | 35 | $172 | $5 |
| Clopidogrel | 13 | $143 | $11 |
| Lisinopril-Hydrochlorothiazide | 12 | $123 | $10 |
| Metoprolol | 15 | $116 | $8 |
| Ibuprofen | 20 | $111 | $6 |
| Furosemide | 14 | $101 | $7 |
| Prednisone | 18 | $64 | $4 |
2018: 55 drugs
| Jardiance | 11 | $13,541 | $1,231 |
| Stiolto Respimat | 30 | $11,329 | $378 |
| Uloric | 12 | $10,064 | $839 |
| Spiriva | 12 | $5,696 | $475 |
| Fluocinonide | 41 | $3,572 | $87 |
| Diclofenac | 87 | $2,841 | $33 |
| Raloxifene | 13 | $2,799 | $215 |
| Ventolin Hfa | 32 | $2,047 | $64 |
| Losartan | 156 | $1,991 | $13 |
| Metoprolol | 59 | $1,812 | $31 |
| Proair Hfa | 23 | $1,564 | $68 |
| Duloxetine | 17 | $1,531 | $90 |
| Atorvastatin | 100 | $1,332 | $13 |
| Losartan-Hydrochlorothiazide | 70 | $1,304 | $19 |
| Entecavir | 12 | $1,250 | $104 |
| Triamcinolone Acetonide | 74 | $1,013 | $14 |
| Warfarin | 38 | $977 | $26 |
| Tamsulosin | 42 | $923 | $22 |
| Amlodipine Besylate | 87 | $904 | $10 |
| Allopurinol | 37 | $890 | $24 |
| Levothyroxine | 33 | $885 | $27 |
| Lidocaine | 17 | $812 | $48 |
| Alendronate | 81 | $780 | $10 |
| Simvastatin | 90 | $762 | $8 |
| Proctozone-Hc | 11 | $704 | $64 |
| Montelukast | 22 | $605 | $27 |
| Gabapentin | 20 | $580 | $29 |
| Famotidine | 23 | $539 | $23 |
| Metformin | 65 | $528 | $8 |
| Metformin Hcl Er | 30 | $517 | $17 |
| Fluticasone Propionate | 39 | $441 | $11 |
| Glipizide Er | 14 | $324 | $23 |
| Pravastatin | 12 | $305 | $25 |
| Benazepril | 27 | $297 | $11 |
| Pantoprazole | 19 | $291 | $15 |
| Rosuvastatin | 11 | $284 | $26 |
| Naproxen | 32 | $269 | $8 |
| Finasteride | 13 | $237 | $18 |
| Atenolol | 17 | $211 | $12 |
| Meclizine | 23 | $190 | $8 |
| Clopidogrel | 16 | $189 | $12 |
| Terazosin | 12 | $155 | $13 |
| Carvedilol | 11 | $150 | $14 |
| Hydroxyzine | 16 | $150 | $9 |
| Metoprolol | 16 | $150 | $9 |
| Hydrochlorothiazide | 30 | $139 | $5 |
| Ibuprofen | 24 | $125 | $5 |
| Lisinopril | 13 | $121 | $9 |
| Glipizide | 15 | $118 | $8 |
| Lovastatin | 12 | $100 | $8 |
| Omeprazole | 20 | $97 | $5 |
| Lorazepam | 22 | $92 | $4 |
| Potassium Chloride | 11 | $63 | $6 |
| Meloxicam | 12 | $57 | $5 |
| Prednisone | 11 | $46 | $4 |
2017: 28 drugs
| Januvia | 12 | $14,389 | $1,199 |
| Ventolin Hfa | 33 | $2,115 | $64 |
| Fluocinonide | 25 | $1,959 | $78 |
| Diclofenac | 23 | $1,586 | $69 |
| Atorvastatin | 45 | $1,182 | $26 |
| Losartan-Hydrochlorothiazide | 40 | $948 | $24 |
| Metoprolol | 22 | $851 | $39 |
| Warfarin | 35 | $824 | $24 |
| Losartan | 61 | $798 | $13 |
| Proair Hfa | 13 | $740 | $57 |
| Simvastatin | 53 | $735 | $14 |
| Triamcinolone Acetonide | 27 | $583 | $22 |
| Levothyroxine | 16 | $513 | $32 |
| Metformin | 43 | $465 | $11 |
| Allopurinol | 19 | $439 | $23 |
| Alendronate | 20 | $405 | $20 |
| Montelukast | 11 | $319 | $29 |
| Amlodipine Besylate | 34 | $313 | $9 |
| Benazepril | 15 | $281 | $19 |
| Omeprazole | 31 | $276 | $9 |
| Cilostazol | 11 | $228 | $21 |
| Hydrochlorothiazide | 24 | $202 | $8 |
| Atenolol | 14 | $162 | $12 |
| Fluticasone Propionate | 17 | $154 | $9 |
| Naproxen | 16 | $127 | $8 |
| Meclizine | 15 | $101 | $7 |
| Gabapentin | 14 | $88 | $6 |
| Hydroxyzine | 12 | $74 | $6 |
2016: 7 drugs
| Atorvastatin | 14 | $270 | $19 |
| Allopurinol | 14 | $160 | $11 |
| Omeprazole | 19 | $125 | $7 |
| Metformin | 16 | $112 | $7 |
| Naproxen | 17 | $101 | $6 |
| Amoxicillin | 15 | $63 | $4 |
| Hydrochlorothiazide | 14 | $53 | $4 |
Money from drug and device companies
$27 in 2025
| 2025 | 1 | 1 | None | $27 |
| 2024 | 3 | 3 | None | $201 |
| 2023 | 14 | 36 | None | $1,540 |
| 2022 | 15 | 67 | None | $2,133 |
| 2021 | 11 | 61 | None | $1,661 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $27 | 1 payment
|
See the published payment
| Exact Sciences | Meals · 2025-09-24 | Cologuard Collection Kit | $27 |
See earlier years (2024, 2023, 2022, 2021)
2024: $201
| E.R. Squibb & Sons L.L.C. | Reblozyl | $149 | 1 payment
|
| Amgen | Otezla | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $25 | 1 payment
|
2023: $1,540
| AstraZeneca Pharmaceuticals LP | Lokelma | $338 | 8 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $236 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $142 | 3 payments
|
| Abbvie | Vraylar | $135 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
| Lilly USA | Mounjaro | $112 | 2 payments
|
| Gilead Sciences | None | $102 | 1 payment
|
| Novo Nordisk | Rybelsus | $83 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $65 | 3 payments
|
| Merck Sharp & Dohme | Varivax | $63 | 3 payments
|
| Amgen | Evenity | $53 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $38 | 1 payment
|
| GlaxoSmithKline | Shingrix | $30 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
2022: $2,133
| AstraZeneca Pharmaceuticals LP | Farxiga | $504 | 13 payments
|
| Novo Nordisk | Rybelsus | $499 | 12 payments
|
| Gilead Sciences | None | $174 | 8 payments
|
| GlaxoSmithKline | Shingrix | $167 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $149 | 3 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $148 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $129 | 7 payments
|
| Lilly USA | Mounjaro | $101 | 5 payments
|
| Amgen | Evenity | $97 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $54 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $31 | 2 payments
|
| Pfizer | Prevnar 13 | $23 | 1 payment
|
| Mannkind | Afrezza | $22 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $22 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $13 | 2 payments
|
2021: $1,661
| Novo Nordisk | Ozempic | $248 | 9 payments
|
| Amgen | Prolia | $196 | 4 payments
|
| Gilead Sciences | Vemlidy | $195 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $192 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $190 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $188 | 6 payments
|
| GlaxoSmithKline | Shingrix | $153 | 2 payments
|
| Lilly USA | Trulicity | $137 | 9 payments
|
| Pfizer | Prevnar 13 | $91 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $52 | 3 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 99.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841653458
- Licence
- CA 95003081
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-03-31
- NPI last updated
- 2025-12-31
- NPI record certified
- 2025-12-31
This is when the NPI record was last certified, not a medical board exam.